Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bleomycin Intralesional Injections of Cystic Hygromas in Pediatric Patients

NCT07189832 is registered in ClinicalTrials.gov with Delta University for Science and Technology as lead sponsor.

NCT NCT07189832
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07189832 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bleomycin Intralesional Injections of Cystic Hygromas in Pediatric Patients
Lead sponsor
Delta University for Science and Technology
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2024
Completion date
April 1, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphatic malformations